Marshall Islands vs Micronesia, Federated States of: Immunization, Hib3
Immunization, Hib3 over time
- Marshall Islands
- Micronesia, Federated States of
How they compare
Marshall Islands currently reports 72.0% against 71.0% in Micronesia, Federated States of, a difference of 1.0%.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Micronesia, Federated States of ahead.
Marshall Islands ranks 160th and Micronesia, Federated States of ranks 162nd of 191 countries.
Across the 3 decades both report, Marshall Islands averaged higher in 2 and Micronesia, Federated States of in 1.
Head to head by decade
| Decade | Marshall Islands | Micronesia, Federated States of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.9% | 70.9% | 2.0% | Micronesia, Federated States of |
| 2010s | 70.7% | 61.5% | 9.2% | Marshall Islands |
| 2020s | 71.8% | 63.2% | 8.6% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Marshall Islands or Micronesia, Federated States of?
- Marshall Islands, at 72.0% against 71.0% in Micronesia, Federated States of as of 2024.
- What is the difference in immunization, hib3 between Marshall Islands and Micronesia, Federated States of?
- 1.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Micronesia, Federated States of?
- 25 years are reported by both, from 2000 to 2024.
- How do Marshall Islands and Micronesia, Federated States of rank globally for immunization, hib3?
- Marshall Islands ranks 160th and Micronesia, Federated States of ranks 162nd of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.